177 related articles for article (PubMed ID: 33130332)
1. Chaperones and Ubiquitin Ligases Balance Mutant p53 Protein Stability in Esophageal and Other Digestive Cancers.
Martinho MS; Nancarrow DJ; Lawrence TS; Beer DG; Ray D
Cell Mol Gastroenterol Hepatol; 2021; 11(2):449-464. PubMed ID: 33130332
[TBL] [Abstract][Full Text] [Related]
2. Isoforms of RNF128 Regulate the Stability of Mutant P53 in Barrett's Esophageal Cells.
Ray D; Ray P; Ferrer-Torres D; Wang Z; Nancarrow D; Yoon HW; San Martinho M; Hinton T; Owens S; Thomas D; Jiang H; Lawrence TS; Lin J; Lagisetty K; Chang AC; Beer DG
Gastroenterology; 2020 Feb; 158(3):583-597.e1. PubMed ID: 31715145
[TBL] [Abstract][Full Text] [Related]
3. UBCH5 Family Members Differentially Impact Stabilization of Mutant p53 via RNF128 Iso1 During Barrett's Progression to Esophageal Adenocarcinoma.
Ray P; Nancarrow DJ; Ferrer-Torres D; Wang Z; San Martinho M; Hinton T; Wu JH; Wu A; Turgeon DK; Hammer MA; Dame MK; Lawrence TS; O'Brien PJ; Spence JR; Beer DG; Ray D
Cell Mol Gastroenterol Hepatol; 2022; 13(1):129-149. PubMed ID: 34416429
[TBL] [Abstract][Full Text] [Related]
4. SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis.
Li D; Marchenko ND; Moll UM
Cell Death Differ; 2011 Dec; 18(12):1904-13. PubMed ID: 21637290
[TBL] [Abstract][Full Text] [Related]
5. Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cells.
Li D; Marchenko ND; Schulz R; Fischer V; Velasco-Hernandez T; Talos F; Moll UM
Mol Cancer Res; 2011 May; 9(5):577-88. PubMed ID: 21478269
[TBL] [Abstract][Full Text] [Related]
6. The chaperone-associated ubiquitin ligase CHIP is able to target p53 for proteasomal degradation.
Esser C; Scheffner M; Höhfeld J
J Biol Chem; 2005 Jul; 280(29):27443-8. PubMed ID: 15911628
[TBL] [Abstract][Full Text] [Related]
7. Buxus alkaloid compound destabilizes mutant p53 through inhibition of the HSF1 chaperone axis.
Wang YL; Wu W; Su YN; Ai ZP; Mou HC; Wan LS; Luo Y; Qiu MH; Zhang JH
Phytomedicine; 2020 Mar; 68():153187. PubMed ID: 32097779
[TBL] [Abstract][Full Text] [Related]
8. Gambogic acid-induced degradation of mutant p53 is mediated by proteasome and related to CHIP.
Wang J; Zhao Q; Qi Q; Gu HY; Rong JJ; Mu R; Zou MJ; Tao L; You QD; Guo QL
J Cell Biochem; 2011 Feb; 112(2):509-19. PubMed ID: 21268072
[TBL] [Abstract][Full Text] [Related]
9. CHIP chaperones wild type p53 tumor suppressor protein.
Tripathi V; Ali A; Bhat R; Pati U
J Biol Chem; 2007 Sep; 282(39):28441-28454. PubMed ID: 17666403
[TBL] [Abstract][Full Text] [Related]
10. The Janus Face of p53-Targeting Ubiquitin Ligases.
Hao Q; Chen Y; Zhou X
Cells; 2020 Jul; 9(7):. PubMed ID: 32660118
[TBL] [Abstract][Full Text] [Related]
11. Chaperone-mediated autophagy degrades mutant p53.
Vakifahmetoglu-Norberg H; Kim M; Xia HG; Iwanicki MP; Ofengeim D; Coloff JL; Pan L; Ince TA; Kroemer G; Brugge JS; Yuan J
Genes Dev; 2013 Aug; 27(15):1718-30. PubMed ID: 23913924
[TBL] [Abstract][Full Text] [Related]
12. A degradative detour for mutant TP53.
Vakifahmetoglu-Norberg H; Yuan J
Autophagy; 2013 Dec; 9(12):2158-60. PubMed ID: 24145670
[TBL] [Abstract][Full Text] [Related]
13. Chaperoning the guardian of the genome. The two-faced role of molecular chaperones in p53 tumor suppressor action.
Wawrzynow B; Zylicz A; Zylicz M
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):161-174. PubMed ID: 29355591
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide reactivates proteasome-dependent degradation of mutant p53 protein in cancer cells in part via enhanced expression of Pirh2 E3 ligase.
Yan W; Jung YS; Zhang Y; Chen X
PLoS One; 2014; 9(8):e103497. PubMed ID: 25116336
[TBL] [Abstract][Full Text] [Related]
15. The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent.
Whitesell L; Sutphin PD; Pulcini EJ; Martinez JD; Cook PH
Mol Cell Biol; 1998 Mar; 18(3):1517-24. PubMed ID: 9488468
[TBL] [Abstract][Full Text] [Related]
16. XAF1 directs apoptotic switch of p53 signaling through activation of HIPK2 and ZNF313.
Lee MG; Han J; Jeong SI; Her NG; Lee JH; Ha TK; Kang MJ; Ryu BK; Chi SG
Proc Natl Acad Sci U S A; 2014 Oct; 111(43):15532-7. PubMed ID: 25313037
[TBL] [Abstract][Full Text] [Related]
17. Mutant p53 Sequestration of the MDM2 Acidic Domain Inhibits E3 Ligase Activity.
Yang L; Song T; Cheng Q; Chen L; Chen J
Mol Cell Biol; 2019 Feb; 39(4):. PubMed ID: 30455251
[TBL] [Abstract][Full Text] [Related]
18. RNF125 is a ubiquitin-protein ligase that promotes p53 degradation.
Yang L; Zhou B; Li X; Lu Z; Li W; Huo X; Miao Z
Cell Physiol Biochem; 2015; 35(1):237-45. PubMed ID: 25591766
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a Potent and Selective Degrader for USP7.
Pei Y; Fu J; Shi Y; Zhang M; Luo G; Luo X; Song N; Mi T; Yang Y; Li J; Zhou Y; Zhou B
Angew Chem Int Ed Engl; 2022 Aug; 61(33):e202204395. PubMed ID: 35691827
[TBL] [Abstract][Full Text] [Related]
20. E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma.
Bielskienė K; Bagdonienė L; Mozūraitienė J; Kazbarienė B; Janulionis E
Medicina (Kaunas); 2015; 51(1):1-9. PubMed ID: 25744769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
